Literature DB >> 16807920

Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet.

Kristopher J Bough1, Jonathon Wetherington, Bjørnar Hassel, Jean Francois Pare, Jeremy W Gawryluk, James G Greene, Renee Shaw, Yoland Smith, Jonathan D Geiger, Raymond J Dingledine.   

Abstract

OBJECTIVE: The full anticonvulsant effect of the ketogenic diet (KD) can require weeks to develop in rats, suggesting that altered gene expression is involved. The KD typically is used in pediatric epilepsies, but is effective also in adolescents and adults. Our goal was to use microarray and complementary technologies in adolescent rats to understand its anticonvulsant effect.
METHODS: Microarrays were used to define patterns of gene expression in the hippocampus of rats fed a KD or control diet for 3 weeks. Hippocampi from control- and KD-fed rats were also compared for the number of mitochondrial profiles in electron micrographs, the levels of selected energy metabolites and enzyme activities, and the effect of low glucose on synaptic transmission.
RESULTS: Most striking was a coordinated upregulation of all (n = 34) differentially regulated transcripts encoding energy metabolism enzymes and 39 of 42 transcripts encoding mitochondrial proteins, which was accompanied by an increased number of mitochondrial profiles, a higher phosphocreatine/creatine ratio, elevated glutamate levels, and decreased glycogen levels. Consistent with increased energy reserves, synaptic transmission in hippocampal slices from KD-fed animals was resistant to low glucose.
INTERPRETATION: These data show that a calorie-restricted KD enhances brain metabolism. We propose an anticonvulsant mechanism of the KD involving mitochondrial biogenesis leading to enhanced alternative energy stores.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807920     DOI: 10.1002/ana.20899

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  208 in total

1.  Preventive effects of ketone ester BD-AcAc2 on central nervous system oxygen toxicity and concomitant acute lung injury.

Authors:  Hongjie Yi; Shichong Yu; Yanan Zhang; Runping Li; Dazhi Zhang; Dazhi Zhang; Weigang Xu
Journal:  Diving Hyperb Med       Date:  2018-12-24       Impact factor: 0.887

Review 2.  Modulation of oxidative stress and mitochondrial function by the ketogenic diet.

Authors:  Julie Milder; Manisha Patel
Journal:  Epilepsy Res       Date:  2011-11-09       Impact factor: 3.045

Review 3.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

4.  Adenosine: a fundamental factor formed from Fatty feasts for fighting fits?

Authors:  Jong M Rho
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

5.  How does altered metabolism lead to seizure control? Partially filling the knowledge gap.

Authors:  Jong M Rho
Journal:  Epilepsy Curr       Date:  2010-11       Impact factor: 7.500

Review 6.  Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

7.  Ketogenic Diets for Adults With Highly Refractory Epilepsy.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

8.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

10.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.